Chunyin Wei
Overview
Explore the profile of Chunyin Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Ma S, Lin Q, Wang Q, Zhong W, Wei C, et al.
Mater Today Bio
. 2024 Nov;
29:101326.
PMID: 39606425
Ion interference, including intracellular copper (Cu) overload, disrupts cellular homeostasis, triggers mitochondrial dysfunction, and activates cell-specific death channels, highlighting its significant potential in cancer therapy. Nevertheless, the insufficient intracellular Cu...
2.
Lin Q, Wang H, Chen W, Wei X, Chen J, Deng Y, et al.
Cancer Med
. 2024 Nov;
13(21):e70397.
PMID: 39503247
Introduction: Isobutyric acid (IBA), a short-chain fatty acid, has been unequivocally demonstrated to exert significant influence on the progression of colorectal cancer (CRC). Nevertheless, a comprehensive understanding of its intricate...
3.
Xie W, Huang X, Wei C, Mo X, Ru H, Zhang L, et al.
Technol Cancer Res Treat
. 2022 Feb;
21:15330338211064077.
PMID: 35225701
Inflammation and nutritional status are highly associated with colorectal cancer (CRC) prognosis. This study aimed to evaluate the prognostic value of the preoperative neutrophil-BMI ratio (NBR) in patients with CRC....
4.
Huang L, Liu J, Huang X, Wei C, Mo X, Zhong H, et al.
Technol Cancer Res Treat
. 2021 Aug;
20:15330338211037418.
PMID: 34338056
Background And Purpose: Systemic inflammation and nutritional status have been shown to be associated with the prognosis of colorectal cancer. The purpose of this study was to evaluate the impact...
5.
Wei C, Xie W, Huang X, Mo X, Liu Z, Wu G, et al.
J Cancer
. 2021 Apr;
12(10):2982-2992.
PMID: 33854599
Gastric cancer (GC) is a heterogeneous disease, and alternative splicing (AS) is a powerful universal transcriptional regulatory mechanism that contributes to the occurrence and development of cancer. However, the systematic...
6.
Liu J, Huang X, Liu H, Wei C, Ru H, Qin H, et al.
J Transl Med
. 2021 Jan;
19(1):27.
PMID: 33413474
Background: KRAS gene is the most common type of mutation reported in colorectal cancer (CRC). KRAS mutation-mediated regulation of immunophenotype and immune pathways in CRC remains to be elucidated. Methods:...
7.
Mo X, Huang X, Feng Y, Wei C, Liu H, Ru H, et al.
Oncoimmunology
. 2020 Oct;
9(1):1832347.
PMID: 33117604
Fluoropyrimidine-based chemotherapy is an essential component of systemic chemotherapy for colorectal cancer (CRC). The immune response is implicated in chemotherapy-induced cytotoxicity. Here, we reported an immune risk (Imm-R) model for...
8.
Liu J, Huang X, Yang W, Li C, Li Z, Zhang C, et al.
Cancer Med
. 2020 Feb;
9(7):2363-2371.
PMID: 32027098
Purpose: The overall survival (OS) of patients diagnosed with stage II-III colorectal cancer (CRC) can vary greatly, even between patients with the same tumor stage. We aimed to design a...
9.
Huang X, Liu J, Mo X, Liu H, Wei C, Huang L, et al.
Aging (Albany NY)
. 2019 Oct;
11(19):8270-8293.
PMID: 31586988
Left- and right-sided colon cancer (LC and RC) differ substantially in their molecular characteristics and prognoses, and are thus treated using different strategies. We systematically analyzed alternative splicing (AS) events...
10.
Yang Z, Wei C, Luo Z, Li L
Onco Targets Ther
. 2013 Aug;
6:957-66.
PMID: 23901285
Objective: Human epididymis protein 4 (HE4) has been approved for diagnosing ovarian cancer. The goal of this meta-analysis was to evaluate the clinical value of the serum HE4 in the...